PH12019501225A1 - Modified streptomyces fungicidicus isolates and their use - Google Patents

Modified streptomyces fungicidicus isolates and their use

Info

Publication number
PH12019501225A1
PH12019501225A1 PH12019501225A PH12019501225A PH12019501225A1 PH 12019501225 A1 PH12019501225 A1 PH 12019501225A1 PH 12019501225 A PH12019501225 A PH 12019501225A PH 12019501225 A PH12019501225 A PH 12019501225A PH 12019501225 A1 PH12019501225 A1 PH 12019501225A1
Authority
PH
Philippines
Prior art keywords
isolates
streptomyces fungicidicus
modified streptomyces
modified
fungicidicus
Prior art date
Application number
PH12019501225A
Other languages
English (en)
Inventor
T Mark Zabriskie
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of PH12019501225A1 publication Critical patent/PH12019501225A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
PH12019501225A 2016-12-06 2019-05-31 Modified streptomyces fungicidicus isolates and their use PH12019501225A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662430455P 2016-12-06 2016-12-06
PCT/EP2017/073771 WO2018103905A1 (en) 2016-12-06 2017-09-20 Modified streptomyces fungicidicus isolates and their use

Publications (1)

Publication Number Publication Date
PH12019501225A1 true PH12019501225A1 (en) 2019-09-23

Family

ID=60043150

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12019501225A PH12019501225A1 (en) 2016-12-06 2019-05-31 Modified streptomyces fungicidicus isolates and their use

Country Status (11)

Country Link
JP (2) JP2020500509A (ja)
CN (1) CN110072881A (ja)
BR (1) BR112019011603A2 (ja)
CO (1) CO2019005540A2 (ja)
MX (1) MX2019006586A (ja)
MY (1) MY194438A (ja)
PE (1) PE20190967A1 (ja)
PH (1) PH12019501225A1 (ja)
TW (1) TWI770070B (ja)
UA (1) UA127451C2 (ja)
WO (1) WO2018103905A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019006522A (es) 2016-12-06 2020-02-20 Univ Oregon State Composiciones y metodos para produccion mejorada de enduracidina en una cepa geneticamente modificada de streptomyces fungicidicus.
CN115261258A (zh) * 2022-06-07 2022-11-01 四川汇邦环保科技有限公司 一种降解持久霉素的微生物菌剂

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT269354B (de) * 1965-10-13 1969-03-10 Takeda Chemical Industries Ltd Verfahren zur Herstellung eines neuen Antibiotikums
DE1617881C2 (de) * 1965-10-13 1984-07-05 Takeda Chemical Industries, Ltd., Osaka Antibiotikum Enduracidin und seine Herstellung
US3577530A (en) 1969-07-24 1971-05-04 Squibb & Sons Inc Janiemycin
JPS6038120B2 (ja) * 1980-10-31 1985-08-30 武田薬品工業株式会社 抗生物質エンジユラサイジンの製造法
US8188245B2 (en) 2006-09-29 2012-05-29 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Enduracidin biosynthetic gene cluster from streptomyces fungicidicus
CN101974469B (zh) * 2010-10-22 2012-05-23 安徽丰原发酵技术工程研究有限公司 一种杀真菌素链霉菌突变菌株及其应用
CN103374537B (zh) * 2012-04-25 2015-01-07 牡丹江佰佳信生物科技有限公司 一种制备恩拉霉素的方法及其生产菌株
CN102864114B (zh) * 2012-10-19 2013-11-06 河北圣雪大成制药有限责任公司 一种恩拉霉素高产菌株及其制备方法和应用
CN103740612A (zh) * 2013-12-19 2014-04-23 河北圣雪大成制药有限责任公司 一种高产恩拉霉素菌株及其筛选方法

Also Published As

Publication number Publication date
BR112019011603A2 (pt) 2020-08-18
MY194438A (en) 2022-11-30
PE20190967A1 (es) 2019-07-08
UA127451C2 (uk) 2023-08-30
TW201827590A (zh) 2018-08-01
WO2018103905A1 (en) 2018-06-14
MX2019006586A (es) 2019-08-22
RU2019117260A (ru) 2021-01-11
TWI770070B (zh) 2022-07-11
CO2019005540A2 (es) 2019-05-31
JP2020500509A (ja) 2020-01-16
JP2023012549A (ja) 2023-01-25
RU2019117260A3 (ja) 2021-01-29
CN110072881A (zh) 2019-07-30

Similar Documents

Publication Publication Date Title
MX2019012233A (es) Anticuerpos anti-sirpa.
PH12018501226A1 (en) Methods for treating huntingtons disease
MX2019011916A (es) Anticuerpos anti-lag3.
MX2019014514A (es) Compuestos para tratar la enfermedad de huntington.
MX2019007020A (es) Anticuerpos il-11.
MY191581A (en) Anti-pd-1 antibodies
PH12017500022A1 (en) Carrier-antibody compositions and methods of making and using the same
MX2017015473A (es) Tratamiento contra el cancer por manipulacion de la microflora comensal.
MD4733C1 (ro) Anticorpi anti-TIGIT
MX2019009117A (es) Anticuerpos anti alfa-sinucleina y usos de los mismos.
MX2016016143A (es) Compuestos de [1,2,4]triazol sustituido.
MX2015009106A (es) Composiciones de solución sólida y su uso en el tratamiento del dolor intenso.
CR20210197A (es) Anticuerpos anti-hla-g, composiciones que comprenden anticuerpos anti-hla-g y métodos de uso de anticuerpos anti-hla-g
WO2017214170A3 (en) Baff-r antibodies and uses thereof
PH12018502137A1 (en) Anti-complement factor bb antibodies and uses thereof
MX2020014031A (es) Proteinas heterodimericas y usos de las mismas.
MX2018009325A (es) Compuestos y metodos para tratar enfermedades mediadas por el acido ribonucleico (arn).
MY193650A (en) Extracellular matrix compositions
MX2023010501A (es) Profarmacos de dantroleno y metodos de su uso.
MX2017008390A (es) Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato.
WO2020127145A3 (de) Materialien für elektronische vorrichtungen
NZ742805A (en) Anti-cd22 antibody-maytansine conjugates and methods of use thereof
TW201613977A (en) Angiopoetin-like 4 (ANGPTL4) antibodies and methods of use
SG10201805646WA (en) Angiopoietin-like 4 antibodies and methods of use
PH12019501225A1 (en) Modified streptomyces fungicidicus isolates and their use